Zhejiang Cheng Yi Pharmaceutical Co Ltd
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co.,… Read more
Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) - Total Liabilities
Latest total liabilities as of September 2025: CN¥362.71 Million CNY
Based on the latest financial reports, Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has total liabilities worth CN¥362.71 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zhejiang Cheng Yi Pharmaceutical Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Zhejiang Cheng Yi Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Zhejiang Cheng Yi Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Cheng Yi Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Anhui Huamao Textile Co Ltd
SHE:000850
|
China | CN¥2.69 Billion |
|
Linkage Software Co Ltd
SHG:688588
|
China | CN¥516.56 Million |
|
Haverty Furniture Companies Inc
NYSE:HVT-A
|
USA | $345.68 Million |
|
Minerva S.A
SA:BEEF3
|
Brazil | R$43.49 Billion |
|
Lion Travel Service Co Ltd
TW:2731
|
Taiwan | NT$8.02 Billion |
|
Cosmecca Korea Co. Ltd
KQ:241710
|
Korea | ₩306.68 Billion |
|
MayAir Technology (China) Co. Ltd. A
SHG:688376
|
China | CN¥2.22 Billion |
|
Ooma Inc
NYSE:OOMA
|
USA | $62.72 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Zhejiang Cheng Yi Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Cheng Yi Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual total liabilities of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥463.31 Million | -33.45% |
| 2023-12-31 | CN¥696.15 Million | +10.82% |
| 2022-12-31 | CN¥628.16 Million | +94.11% |
| 2021-12-31 | CN¥323.62 Million | +0.88% |
| 2020-12-31 | CN¥320.79 Million | +51.83% |
| 2019-12-31 | CN¥211.29 Million | +48.33% |
| 2018-12-31 | CN¥142.45 Million | +94.04% |
| 2017-12-31 | CN¥73.41 Million | -12.72% |
| 2016-12-31 | CN¥84.11 Million | -2.44% |
| 2015-12-31 | CN¥86.21 Million | +4.16% |
| 2014-12-31 | CN¥82.77 Million | -37.50% |
| 2013-12-31 | CN¥132.43 Million | -26.42% |
| 2012-12-31 | CN¥179.99 Million | -6.78% |
| 2011-12-31 | CN¥193.09 Million | -- |